Editorial comment.
Rosser
Charles J
CJ
D000726:Androgen Antagonists / Q000009:adverse effects*; D000529:Complementary Therapies; D006801:Humans; D007529:Isoflavones / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists; D007529:Isoflavones